ORTHOWORLD estimates Integra LifeSciences’ 3Q17 orthopaedic revenue at US $26.2MM, +4.8% from 3Q16, and year-to-date revenue of $80.3MM, +9.1% vs. the prior year.
Arthrosurface acquired IP from WASAS pertaining to an acellular dermal stabilization allograft device that may address various orthopaedic therapeutic challenges.
Stryker Performance Solutions launched Practice Excellence™ to help U.S. orthopaedic practices drive profitability, efficiency and quality outcomes.